Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer.

Lee CH, Kuo WH, Lin CC, Oyang YJ, Huang HC, Juan HF.

Int J Mol Sci. 2013 May 30;14(6):11560-606. doi: 10.3390/ijms140611560.

2.

Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis.

Yang Y, Xing Y, Liang C, Hu L, Xu F, Chen Y.

Tumour Biol. 2015 Jul;36(7):5571-9. doi: 10.1007/s13277-015-3227-3. Epub 2015 Feb 14.

PMID:
25680412
3.

Analysis of serum genome-wide microRNAs for breast cancer detection.

Wu Q, Wang C, Lu Z, Guo L, Ge Q.

Clin Chim Acta. 2012 Jul 11;413(13-14):1058-65. doi: 10.1016/j.cca.2012.02.016. Epub 2012 Feb 23.

PMID:
22387599
4.

Regulation of Heat Shock Proteins by miRNAs in human breast cancer.

Ozgur A, Tutar L, Tutar Y.

Microrna. 2014;3(2):118-35.

PMID:
25541910
5.

High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.

Leivonen SK, Sahlberg KK, Mäkelä R, Due EU, Kallioniemi O, Børresen-Dale AL, Perälä M.

Mol Oncol. 2014 Feb;8(1):93-104. doi: 10.1016/j.molonc.2013.10.001. Epub 2013 Oct 11.

6.

Integrative network analysis reveals active microRNAs and their functions in gastric cancer.

Tseng CW, Lin CC, Chen CN, Huang HC, Juan HF.

BMC Syst Biol. 2011 Jun 26;5:99. doi: 10.1186/1752-0509-5-99.

7.

Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.

Eissa S, Matboli M, Shehata HH.

Transl Res. 2015 Mar;165(3):417-27. doi: 10.1016/j.trsl.2014.10.001. Epub 2014 Oct 31.

PMID:
25445205
8.

Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.

Ye S, Yang L, Zhao X, Song W, Wang W, Zheng S.

Cell Biochem Biophys. 2014 Dec;70(3):1849-58. doi: 10.1007/s12013-014-0142-y.

PMID:
25087086
9.

MicroRNAs and their target gene networks in breast cancer.

O'Day E, Lal A.

Breast Cancer Res. 2010;12(2):201. doi: 10.1186/bcr2484. Epub 2010 Mar 19. Review.

10.

Identification of circulating microRNA signatures for breast cancer detection.

Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.

Clin Cancer Res. 2013 Aug 15;19(16):4477-87. doi: 10.1158/1078-0432.CCR-12-3401. Epub 2013 Jun 24.

11.

Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.

Jayavelu ND, Bar N.

BMC Genomics. 2015 Dec 18;16:1077. doi: 10.1186/s12864-015-2260-3.

12.

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.

Tahiri A, Leivonen SK, Lüders T, Steinfeld I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Børresen-Dale AL, Perälä M, Bukholm IR, Kristensen VN.

Carcinogenesis. 2014 Jan;35(1):76-85. doi: 10.1093/carcin/bgt333. Epub 2013 Oct 8.

PMID:
24104550
13.

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.

Mol Oncol. 2014 Jul;8(5):874-83. doi: 10.1016/j.molonc.2014.03.002. Epub 2014 Mar 16.

14.

Reconstructing the coding and non-coding RNA regulatory networks of miRNAs and mRNAs in breast cancer.

Yang S, Zhang H, Guo L, Zhao Y, Chen F.

Gene. 2014 Sep 10;548(1):6-13. doi: 10.1016/j.gene.2014.06.010. Epub 2014 Jun 27.

PMID:
24979338
15.

miRNA expression patterns in chemoresistant breast cancer tissues.

Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H.

Biomed Pharmacother. 2014 Oct;68(8):935-42. doi: 10.1016/j.biopha.2014.09.011. Epub 2014 Oct 5.

PMID:
25451164
16.

Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.

Zhu M, Yi M, Kim CH, Deng C, Li Y, Medina D, Stephens RM, Green JE.

Genome Biol. 2011 Aug 16;12(8):R77. doi: 10.1186/gb-2011-12-8-r77.

17.

Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.

Tanic M, Zajac M, Gómez-López G, Benítez J, Martínez-Delgado B.

Breast Cancer Res Treat. 2012 Jul;134(1):41-51. doi: 10.1007/s10549-011-1905-4. Epub 2011 Dec 14.

PMID:
22167321
18.

Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.

Mar-Aguilar F, Luna-Aguirre CM, Moreno-Rocha JC, Araiza-Chávez J, Trevino V, Rodríguez-Padilla C, Reséndez-Pérez D.

Asia Pac J Clin Oncol. 2013 Mar;9(1):53-9. doi: 10.1111/j.1743-7563.2012.01548.x. Epub 2012 Jul 23.

PMID:
22898264
19.

MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.

Zhao L, Sun Y, Hou Y, Peng Q, Wang L, Luo H, Tang X, Zeng Z, Liu M.

Int J Biochem Cell Biol. 2012 Nov;44(11):2051-9. doi: 10.1016/j.biocel.2012.08.005. Epub 2012 Aug 13.

PMID:
22964023
20.

MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.

Ward A, Shukla K, Balwierz A, Soons Z, König R, Sahin O, Wiemann S.

J Pathol. 2014 Aug;233(4):368-79. doi: 10.1002/path.4363. Epub 2014 Jun 2.

Supplemental Content

Support Center